FindTrial
Sign In

Clinical observation on real events of severe dengue fever treated with traditional Chinese Medicine

Clinical study of ganghuokanggan Decoction on dengue fever

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2100004501
Enrollment
Unknown
Registered
2021-02-28
Start date
2021-04-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dengue fever

Interventions

Group 2:Antipyretic and Antitoxic Decoction
Group 1:Ganghuo Kanggan granule
Group 3:Fuzi Lizhong Decoction and Huangtu Decoction

Sponsors

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Patients who met the diagnostic criteria for secondary infection of dengue fever. (2) Those who meet any of the early warning indications for severe dengue fever. (3) Patients with severe dengue fever met the diagnostic criteria. (4) According to GCP, informed consent was obtained and volunteers were enrolled.

Exclusion criteria

Exclusion criteria: Nil

Design outcomes

Primary

MeasureTime frame
Effect of traditional Chinese medicine intervention on mortality;Serum dengue virus load;—

Secondary

MeasureTime frame
Antipyretic time;APACHE III score;Clinical symptoms of dengue fever;TCM syndrome;Routine laboratory indicators;—

Countries

China

Contacts

Public ContactLiu Xiaohong

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

rsclxh@gzucm.edu.cn+86 13926002208

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026